Abstract
The renoprotective effect of thymol (TML) was investigated in rats challenged with gentamicin (GN). Rats received TML (20 mg/kg/day, p.o.) for 15 days, and GN (80 mg/kg/day, i.p.) starting from the 8th day. TML significantly lowered serum creatinine and neutrophil gelatinase-associated lipocalin, and renal malondialdehyde, nitric oxide, tumor necrosis factor-α, interleukin-18, Bax, caspase-3, and caspase-9 in GN-challenged rats. In addition, TML caused a significant increment of renal total antioxidant capacity in rats received GN. Moreover, TML significantly ameliorated GN-induced histopathological kidney tissue injury, and significantly decreased nuclear factor-κB p65 and kidney injury molecule-1 expressions in kidneys of GN-challenged rats. It was concluded that TML guarded against CN-induced nephrotoxicity in rats via inhibition of oxidative stress, inflammation, and apoptosis.
Highlights
Gentamicin (GN), an antibiotic related to aminoglycosides, is commonly used to treat serious infections caused by aerobic Gram-negative bacilli
Administration of GN (80 mg/kg/day, i.p.) for 8 days resulted in significant increases of serum creatinine and neutrophil gelatinase-associated lipocalin (NGAL) (p < 0.05) in comparison with the control values (Fig. 1A)
TML caused significant decrements of renal nuclear factor-κB (NF-κB) p65 and kidney injury molecule-1 (KIM-1) expressions (p < 0.05) in rats challenged with GN (Figs 3, 4)
Summary
Gentamicin (GN), an antibiotic related to aminoglycosides, is commonly used to treat serious infections caused by aerobic Gram-negative bacilli. Despite its efficacy in bacterial eradication, GN-induced nephrotoxicity is considered a major adverse effect which limits its usefulness (Hayward et al 2018; Srisung et al 2017). A well-built evidence proposes that increased manufacturing of reactive oxygen species (ROS) and reactive nitrogen species (RNS), are implicated in GN-induced AKI.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
